A 62-year-old man presents with “yellowing” of the skin. He says he has been having intermittent upper abdominal pain, which is relieved by Tylenol. He also recalls that he has lost some weight over the past several months but can not quantify the amount. His past medical history is significant for type 2 diabetes mellitus. He reports a 40-pack-year smoking history. The patient is afebrile and vital signs are within normal limits. Physical examination reveals mild jaundice and a palpable gallbladder. Laboratory findings are significant for the following: Total bilirubin 13 mg/dL Direct bilirubin: 10 mg/dL Alkaline phosphatase (ALP): 560 IU/L An ultrasound of the abdomen reveals a hypoechoic mass in the epigastric region. The patient is scheduled for a CT abdomen and pelvis with specific organ protocol for further evaluation. Which of the following best describes this patient’s most likely diagnosis?

CA 19-9 is a marker for this condition.

Caffeine consumption is an established risk factor for this condition.

Patients with this condition often rapidly develop glucose intolerance and severe diabetes.

This condition is most common in Caucasians.

The majority of cases occur in the body of the pancreas.

A 70-year-old male visits his primary care physician because of progressive weight loss. He has a 20-year history of smoking 2 packs of cigarettes a day and was diagnosed with diabetes mellitus 6 years ago. After physical examination, the physician tells the patient he suspects adenocarcinoma at the head of the pancreas. Which of the following physical examination findings would support the diagnosis?

Lymphadenopathy of the umbilicus

A 55-year old man living in Midwest USA comes in complaining of painless hematuria for the past week. He denies dysuria but complains of fatigue and lethargy at work. He has lost about 9.0 kg (20.0 lb) in the past 6 months. He drinks 1–2 beers on the weekends over the past 10 years but denies smoking. He has worked at a plastic chemical plant for the past 30 years and has never been out of the country. His father died of a heart attack at age 62 and his mother is still alive and well. There is a distant history of pancreatic cancer, but he can not remember the specifics. His vitals are stable and his physical exam is unremarkable. Urinary analysis is positive for RBCs. A cystoscopy is performed and finds a pedunculated mass projecting into the bladder lumen. A biopsy shows malignant cells. Which of the following is the most concerning risk factor for this patient’s condition?

Schistosoma haematobium infection

A 46-year-old woman presents to her primary care physician for her annual examination. At her prior exam one year earlier, she had a Pap smear which was within normal limits. Which of the following health screenings is recommended for this patient?

Blood glucose and/or HbA1c screening

Blood pressure at least once every 3 years

A 21-year-old college student comes to the emergency department because of a two-day history of vomiting and epigastric pain that radiates to the back. He has a history of atopic dermatitis and Hashimoto thyroiditis. His only medication is levothyroxine. He has not received any routine vaccinations. He drinks 1–2 beers on the weekends and occasionally smokes marijuana. The patient appears distressed and is diaphoretic. His temperature is 37.9°C (100.3°F), pulse is 105/min, respirations are 16/min, and blood pressure is 130/78 mm Hg. Physical examination shows abdominal distention with tenderness to palpation in the epigastrium. There is no guarding or rebound tenderness. Skin examination shows several clusters of yellow plaques over the trunk and extensor surfaces of the extremities. Hemoglobin concentration is 15.2 g/dL and serum calcium concentration is 7.9 mg/dL. Which of the following is the most appropriate next step in evaluation?

Obtain an upright x-ray of the abdomen

Perform a pilocarpine-induced sweat test

Pancreatic cancer risk in chronic pancreatitis for USMLE Step 3: High-Yield Internal Medicine Lessons

Risk Factors - The Unholy Alliance

Chronic pancreatitis is a major premalignant condition, elevating pancreatic ductal adenocarcinoma (PDAC) risk significantly. The lifetime risk for PDAC in chronic pancreatitis is ~5%, with a standardized incidence ratio (SIR) of 15-20.

Key Drivers of Malignant Transformation:
- Hereditary Pancreatitis: Carries the highest risk, especially with PRSS1 gene mutations. Lifetime risk approaches 40% by age 70.
- Smoking: The most potent modifiable risk factor; it doubles the cancer risk.
- Alcohol: Acts synergistically with other factors to accelerate carcinogenesis.
- Genetic Susceptibility: SPINK1 mutations also confer increased risk.

⭐ The risk of developing cancer is highest 5-9 years after the initial diagnosis of chronic pancreatitis.

Pancreatic cancer development in chronic pancreatitis

Pathophysiology - Scar to Malignant Star

Chronic inflammation acts as a potent tumor promoter. The 'inflammation-fibrosis-carcinoma' sequence transforms pancreatic tissue through a multi-step process driven by both environmental and genetic insults.

Inflammatory Milieu: Persistent injury triggers a cytokine storm (e.g., TNF-α, IL-6), promoting cell turnover and oxidative stress, which directly damages DNA.
Genetic Progression: An accumulation of mutations in key genes drives malignant transformation.
- KRAS oncogene activation (early event)
- p16/CDKN2A inactivation
- p53 and SMAD4/DPC4 tumor suppressor loss (late events)

⭐ Loss of SMAD4 (DPC4) protein expression is found in ~55% of pancreatic cancers and is highly specific for this malignancy.

Pancreatic cancer progression from acinar cells to PDAC

📌 Mnemonic: Cancer's Killer Pathway Starts here: KRAS → p16 → p53 → SMAD4.

Screening & Surveillance - Cancer Watch

High-Risk Cohorts for Screening:
- Hereditary pancreatitis (e.g., PRSS1 mutations): Start at age 40, or 15-20 years after disease onset.
- Strong family history (≥2 first-degree relatives with pancreatic cancer).
- Genetic syndromes (e.g., Peutz-Jeghers, PALB2, BRCA1/2).
Screening Protocol:

Key Points:
- Primary modalities are EUS and MRI/MRCP; they are complementary.
- CA 19-9 is not a screening test due to poor sensitivity/specificity. It's mainly for monitoring diagnosed cancer. Can be elevated in benign cholestasis.

⭐ New-onset diabetes mellitus in a patient >50 years old, particularly with unintentional weight loss, can be the first presentation of an underlying pancreatic adenocarcinoma.

High‑Yield Points - ⚡ Biggest Takeaways

Chronic pancreatitis is the single strongest risk factor for developing pancreatic adenocarcinoma.

The risk is significantly amplified in hereditary and tropical pancreatitis.

Risk escalates with the duration of the disease, particularly after 10-20 years.

Smoking and alcohol are independent risk factors that act synergistically with chronic pancreatitis.

Cancer screening is typically reserved for high-risk subgroups, not for all patients.

New-onset diabetes in this population warrants a high suspicion for malignancy.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play